MEN1
- Animals2
Latest
ADA Scientific Sessions 2025 Abstract
Combination Therapy of Icovamenib and Semaglutide Enhances Body Weight Loss and Glycemic Control While Increasing Lean Mass in a Type 2 Diabetes Animal Model
Experiments in ratsSemaglutide
ADA Scientific Sessions 2025 Abstract
Icovamenib Rescues Human Myotube Atrophy Ex Vivo and Displays Complete Lean Mass Preservation in a Type 2 Diabetes Rat Model
Experiments in ratsInterventions